[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] # $atos $ATOS announces issuance of U.S. patent covering oral (Z)-Endoxifen formulations. Social media buzz highlights upcoming catalysts and positive data presentations. ### About $atos Atossa Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapeutics for breast cancer. ### Insights - $atos sentiment is up XXXXX% from the previous month. - $atos creators is up XXXXX% from the previous week. - $atos engagements is up XXXXX% from the previous week. - $atos mentions is up XXXXX% from the previous week. ### Engagements: XXXXX (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$atos/time-series/interactions.tsv) Current Value: XXXXX Daily Average: XXXXX X Week: XXXXX +71% X Month: XXXXXX +4.70% X Months: XXXXXXX -XX% X Year: XXXXXXXXX -XX% 1-Year High: XXXXXX on 2025-07-30 1-Year Low: XXX on 2025-11-15 Engagements by network (24h): X: XXXXX YouTube: XX ### Mentions: XX (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$atos/time-series/posts_active.tsv) Current Value: XX Daily Average: XX X Week: XXX +53% X Month: XXX -XX% X Months: XXXXX -XX% X Year: XXXXX -XX% 1-Year High: XXX on 2024-12-13 1-Year Low: XX on 2025-09-28 Mentions by network (24h): X: XXX YouTube: X ### Creators: XX (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$atos/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning $atos in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX X Week: XX +79% X Month: XXX -XX% X Months: XXXXX +156% X Year: XXXXX +166% 1-Year High: XXX on 2025-06-28 1-Year Low: X on 2025-09-07 The most influential creators that mention $atos in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X | XXXXXX | X | XXXXX | | [@JeffTheOmega1](/creator/twitter/JeffTheOmega1) | X | XXXXX | X | XXX | | [@Hilljohan750](/creator/twitter/Hilljohan750) | X | XX | X | XX | | [@remon_jon83640](/creator/twitter/remon_jon83640) | X | X | X | X | [View More](/list/creators/$atos/100) ### Sentiment: XX%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$atos/time-series/sentiment.tsv) Current Value: XX% Daily Average: XX% X Week: XXX% +12% X Month: XXX% +14% X Months: XXX% +4% X Year: XXX% +12% 1-Year High: XXX% on 2024-12-18 1-Year Low: XX% on 2025-10-16 Most Supportive Themes: - Trading Group Promotions: (40%) Users are actively promoting $ATOS within trading groups, suggesting a coordinated effort to drive interest and potential price appreciation. - Mainnet Launch and Airdrop: (30%) Anticipation for the 2026 mainnet launch and associated airdrop is a significant driver of current social buzz and price speculation. - FDA Feedback and Clinical Trials: (20%) Positive feedback from the FDA and progress in clinical trials are contributing to a favorable outlook for $ATOS. Most Critical Themes: - Fear of Missing Out (FOMO): (10%) Some users express anxiety about missing out on potential gains, indicating a speculative element within the community. ### Top $atos Social Posts Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Best discord group over 180k members and even have their own app join here $TWTR $GILD $DAL $NNDM $WISH $SRNE $CRON $ATOS $THCH $BTC $ETH $XRP #orderblocktrading" [X Link](https://x.com/MSdzvd66208/status/1998439002979111024) [@MSdzvd66208](/creator/x/MSdzvd66208) 2025-12-09T17:06Z XX followers, XX engagements "📌 Biotech Stock News 12/10 @ Open $XCUR XX% Burixafor Topline Data @ ASH'25 $WVE X% $250M Public Offering $TERN X% TERN-701 Ph1 Data; $400M Public Offering $ASMB X% ABI-1179 & ABI-5366 Interim Results $CRDF X% Onvansertib Data @ ASH'25 $ATOS X% Endoxifen U.S. Patent $GPCR X% $500M Public Offering $COYA X% Patients Dosed in ALSTARS Trial $TEVA X% Submits NDA for Olanzapine $ALC X% Amended Merger Agreement $JNJ X% Ph3 study supports new treatment $CTXR X% $18M Offering & Placement $OSTX X% OST-HER2 pre-Marketing Authorisation Mtg $CRIS X% Updated Data from Frontline AML Study $INCY 0%" [X Link](https://x.com/BiopharmIQ/status/1998432564135309794) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-12-09T16:40Z 28.1K followers, 3443 engagements "$ATOS +2.76% today as Atossa Therapeutics Announces Issuance of U.S. Patent Covering Enteric Oral (Z)-Endoxifen Formulations and Methods of Treating Patients Using (Z)-Endoxifen More Info:" [X Link](https://x.com/OzmosiHealth/status/1998422016311910719) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-12-09T15:58Z 3011 followers, XXX engagements "$ATOS Daily Inv H&S Daily MACD RSI curling Multiple catalysts starting today with data presentation X exhibits going on 12+ months of cash $50m No dilution during 2025 All warrants expired Recent upgraded to $8" [X Link](https://x.com/JeffTheOmega1/status/1998404526886236463) [@JeffTheOmega1](/creator/x/JeffTheOmega1) 2025-12-09T14:49Z 4649 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$ATOS announces issuance of U.S. patent covering oral (Z)-Endoxifen formulations. Social media buzz highlights upcoming catalysts and positive data presentations.
Atossa Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapeutics for breast cancer.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXX +71%
X Month: XXXXXX +4.70%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXX on 2025-07-30
1-Year Low: XXX on 2025-11-15
Engagements by network (24h): X: XXXXX YouTube: XX
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX +53%
X Month: XXX -XX%
X Months: XXXXX -XX%
X Year: XXXXX -XX%
1-Year High: XXX on 2024-12-13
1-Year Low: XX on 2025-09-28
Mentions by network (24h): X: XXX YouTube: X
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $atos in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX +79%
X Month: XXX -XX%
X Months: XXXXX +156%
X Year: XXXXX +166%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-07
The most influential creators that mention $atos in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | X | XXXXXX | X | XXXXX |
| @JeffTheOmega1 | X | XXXXX | X | XXX |
| @Hilljohan750 | X | XX | X | XX |
| @remon_jon83640 | X | X | X | X |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% +12%
X Month: XXX% +14%
X Months: XXX% +4%
X Year: XXX% +12%
1-Year High: XXX% on 2024-12-18
1-Year Low: XX% on 2025-10-16
Most Supportive Themes:
Most Critical Themes:
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Best discord group over 180k members and even have their own app join here $TWTR $GILD $DAL $NNDM $WISH $SRNE $CRON $ATOS $THCH $BTC $ETH $XRP #orderblocktrading"
X Link @MSdzvd66208 2025-12-09T17:06Z XX followers, XX engagements
"📌 Biotech Stock News 12/10 @ Open $XCUR XX% Burixafor Topline Data @ ASH'25 $WVE X% $250M Public Offering $TERN X% TERN-701 Ph1 Data; $400M Public Offering $ASMB X% ABI-1179 & ABI-5366 Interim Results $CRDF X% Onvansertib Data @ ASH'25 $ATOS X% Endoxifen U.S. Patent $GPCR X% $500M Public Offering $COYA X% Patients Dosed in ALSTARS Trial $TEVA X% Submits NDA for Olanzapine $ALC X% Amended Merger Agreement $JNJ X% Ph3 study supports new treatment $CTXR X% $18M Offering & Placement $OSTX X% OST-HER2 pre-Marketing Authorisation Mtg $CRIS X% Updated Data from Frontline AML Study $INCY 0%"
X Link @BiopharmIQ 2025-12-09T16:40Z 28.1K followers, 3443 engagements
"$ATOS +2.76% today as Atossa Therapeutics Announces Issuance of U.S. Patent Covering Enteric Oral (Z)-Endoxifen Formulations and Methods of Treating Patients Using (Z)-Endoxifen More Info:"
X Link @OzmosiHealth 2025-12-09T15:58Z 3011 followers, XXX engagements
"$ATOS Daily Inv H&S Daily MACD RSI curling Multiple catalysts starting today with data presentation X exhibits going on 12+ months of cash $50m No dilution during 2025 All warrants expired Recent upgraded to $8"
X Link @JeffTheOmega1 2025-12-09T14:49Z 4649 followers, XXX engagements
/topic/$atos